Most frequent investigator-reported treatment-emergent drug-related adverse events reported in the ITT (safety) population (≥2% of patients in either treatment group).
收藏NIAID Data Ecosystem2026-03-06 收录
数据链接：
官方服务：
资源简介：
Most frequent investigator-reported treatment-emergent drug-related adverse events reported in the ITT (safety) population (≥2% of patients in either treatment group).
创建时间：
2009-08-19
